Article thumbnail

Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa

By Alexandra Brand, Julia D Barnes, Kevin S Mackenzie, Frank C Odds and Neil AR Gow


The fungus, Candida albicans, and the bacterium, Pseudomonas aeruginosa, are opportunistic human pathogens that have been coisolated from diverse body sites. Pseudomonas aeruginosa suppresses C. albicans proliferation in vitro and potentially in vivo but it is the C. albicans hyphae that are killed while yeast cells are not. We show that hyphal killing involves both contact-mediated and soluble factors. Bacterial culture filtrates contained heat-labile soluble factors that killed C. albicans hyphae. In cocultures, localized points of hyphal lysis were observed, suggesting that adhesion and subsequent bacteria-mediated cell wall lysis is involved in the killing of C. albicans hyphae. The glycosylation status of the C. albicans cell wall affected the rate of contact-dependent killing because mutants with severely truncated O-linked, but not N-linked, glycans were hypersensitive to Pseudomonas-mediated killing. Deletion of HWP1, ALS3 or HYR1, which encode major hypha-associated cell wall proteins, had no effect on fungal susceptibility

Topics: Research Letter
Publisher: Blackwell Publishing Ltd
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). 48–55 r
  2. (2004). A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology.
  3. (1999). Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.
  4. (1995). aeruginosa to C. albicans is likely to be mediated by the outer, glycoprotein-rich layer of the fungal cell wall. It has been reported that P. aeruginosa requires glycoproteins as adhesion sites on host kidney cells
  5. (2007). Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells.
  6. (1998). Altered adherence in strains of Candida albicans with null mutations in secreted aspartic proteinase genes.
  7. (2008). An integrated model of recognition of Candida albicans in innate immunity.
  8. (2003). beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro.
  9. (2004). Ca44 hyr1D Mutant lacking a hypha-specific cell wall protein 3.70.6 Bailey
  10. (1998). Candida albicans ALS3 and insights into the nature of the ALS gene family.
  11. (2005). Candida albicans Pmr1p: a secretory pathway Ca 21/Mn 21 P-type ATPase required for glycosylation and virulence.
  12. (2002). Cell biology and cell cycle of Candida. Candida and Candidiasis
  13. (1995). Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.
  14. (2002). Co-regulation of pathogenesis with dimorphism and phenotypic switching in Candida albicans, a commensal and a pathogen.
  15. (1997). Control of filament formation in Candida albicans by the transcriptional repressor TUP1.
  16. (2004). Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.
  17. (2003). Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.
  18. (1994). Growth inhibition of pathogenic yeasts by Pseudomonas aeruginosa in vitro: clinical implications in blood cultures.
  19. (2004). Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis.
  20. (1990). Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications.
  21. (2006). Immune sensing of Candida albicans: cooperative recognition of mannans and glucan by lectin and Toll-like receptors.
  22. (2004). Induced reversion to the yeast form by P. aeruginosa secretion of 3-oxo-C12-homoserine lactone in media that otherwise favored hyphal growth resulted in survival of
  23. (2003). Invitro studies on colonization resistance of the human gut microbiota to Candida albicans and the effects of tetracyclin and Lactobacillus plantarum LPK.
  24. (1993). Isogenic strain construction and gene mapping in Candida albicans.
  25. (1999). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to FEMS
  26. (2004). Loss of cell wall mannosylphosphate in Candida albicans does not influence macrophage recognition.
  27. (2005). Mnt1p and Mnt2p of Candida albicans are functionally redundant a-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence.
  28. (2000). Morphogenesis, adhesive properties and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen Candida albicans.
  29. (2006). Outer chain Nglycans are required for cell wall integrity and virulence of Candida albicans.
  30. (2003). Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis.
  31. (1999). Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.
  32. (2002). Pseudomonas–Candida interactions: an ecological role for virulence factors.
  33. (1999). Role of dimorphism in the development of Candida albicans biofilms.
  34. (1994). Suppression of fungal growth exhibited by Pseudomonas aeruginosa.
  35. (1996). The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins.
  36. (2001). Ura-statusdependent adhesion of Candida albicans mutants.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.